Tobacco Smoke–Related Diffuse Lung Diseases

ABSTRACT

Cigarette smoking has been associated with several diffuse lung diseases in which both bronchiolar and interstitial lung inflammation appear to result from chronic tobacco smoke inhalation. These diseases occur primarily in relatively young adult smokers and include desquamative interstitial pneumonia, respiratory bronchiolitis–associated interstitial lung disease, and pulmonary Langerhans cell histiocytosis. Although these diseases are associated with characteristic histopathologic and radiological features, there is significant overlap among these diseases, and some smokers may exhibit features indicative of the broad spectrum of smoking-related interstitial and bronchiolar lung injury patterns. Cigarette smoking has also been associated with acute eosinophilic pneumonia, and it increases the risk of developing other fibrotic interstitial lung diseases such as idiopathic pulmonary fibrosis and rheumatoid arthritis–associated interstitial lung disease. Although relatively uncommon, these smoking-related diffuse lung diseases should be recognized by clinicians as an important subset in the spectrum of interstitial lung diseases in which smoking cessation forms a central part of disease management. With the exception of acute eosinophilic pneumonia, which responds well to corticosteroid therapy, the role of corticosteroid and other immune-suppressive treatments in the management of smoking-related interstitial lung diseases is not entirely clear and is probably of limited utility, particularly in the absence of smoking cessation.

Respiratory bronchiolitis - desquamative interstitial pneumonia - interstitial lung disease - smoking - pulmonary Langerhans cell histiocytosis - acute eosinophilic pneumonia

REFERENCES

• 1 Ryu J H, Myers J L, Capizzi S A et al.. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease.  Chest. 2005;  127 178-184
• 2 Vassallo R, Ryu J H, Schroeder D R et al.. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults.  N Engl J Med. 2002;  346 484-490
• 3 Moon J, du Bois R M, Colby T V et al.. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease.  Thorax. 1999;  54 1009-1014
• 4 Friedman P J, Liebow A A, Sokoloff J. Eosinophilic granuloma of lung: clinical aspects of primary histiocytosis in the adult.  Medicine (Baltimore). 1981;  60 385-396
• 5 Nakanishi M, Demura Y, Mizuno S et al.. Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation.  Eur Respir J. 2007;  29 453-461
• 6 Vassallo R, Jensen E A, Colby T V et al.. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations.  Chest. 2003;  124 1199-1205
• 7 Niewoehner D E, Kleinerman J, Rice D B. Pathologic changes in the peripheral airways of young cigarette smokers.  N Engl J Med. 1974;  291 755-758
• 8 Remy-Jardin M, Remy J, Gosselin B et al.. Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations.  Radiology. 1993;  186 643-651
• 9 Fraig M, Shreesha U, Savici D et al.. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers.  Am J Surg Pathol. 2002;  26 647-653
• 10 Myers J L, Veal Jr C F, Shin M S et al.. Respiratory bronchiolitis causing interstitial lung disease: a clinicopathologic study of six cases.  Am Rev Respir Dis. 1987;  135 880-884
• 11 Yousem S A, Colby T V, Gaensler E A. Respiratory bronchiolitis–associated interstitial lung disease and its relationship to desquamative interstitial pneumonia.  Mayo Clin Proc. 1989;  64 1373-1380
• 12 Mavridou D, Laws D. Respiratory bronchiolitis associated interstitial lung disease (RB-ILD): a case of an acute presentation.  Thorax. 2004;  59 910-911
• 13 Portnoy J, Veraldi K L, Schwarz M I et al.. Respiratory bronchiolitis–interstitial lung disease: long-term outcome.  Chest. 2007;  131 664-671
• 14 Craig P J, Wells A U, Doffman S et al.. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking.  Histopathology. 2004;  45 275-282
• 15 Liebow A A, Steer A, Billingsley J G. Desquamative interstitial pneumonia.  Am J Med. 1965;  39 369-404
• 16 Paul K, Klettke U, Moldenhauer J et al.. Increasing dose of methylprednisolone pulse therapy treats desquamative interstitial pneumonia in a child.  Eur Respir J. 1999;  14 1429-1432
• 17 Lougheed M D, Roos J O, Waddell W R et al.. Desquamative interstitial pneumonitis and diffuse alveolar damage in textile workers: potential role of mycotoxins.  Chest. 1995;  108 1196-1200
• 18 Flores-Franco R A, Luevano-Flores E, Gaston-Ramirez C. Sirolimus-associated desquamative interstitial pneumonia.  Respiration. 2007;  74 237-238
• 19 Iskandar S B, McKinney L A, Shah L et al.. Desquamative interstitial pneumonia and hepatitis C virus infection: a rare association.  South Med J. 2004;  97 890-893
• 20 Patchefsky A S, Fraimow W, Hoch W S. Desquamative interstitial pneumonia: pathological findings and follow-up in 13 patients.  Arch Intern Med. 1973;  132 222-225
• 21 Flusser G, Gurman G, Zirkin H et al.. Desquamative interstitial pneumonitis causing acute respiratory failure, responsive only to immunosuppressants.  Respiration. 1991;  58 324-326
• 22 Matsuo K, Tada S, Kataoka M et al.. Spontaneous remission of desquamative interstitial pneumonia.  Intern Med. 1997;  36 728-731
• 23 Verleden G M, Sels F, Van Raemdonck D et al.. Possible recurrence of desquamative interstitial pneumonitis in a single lung transplant recipient.  Eur Respir J. 1998;  11 971-974
• 24 Agostini C, Albera C, Bariffi F et al.. First report of the Italian register for diffuse infiltrative lung disorders (RIPID).  Monaldi Arch Chest Dis. 2001;  56 364-368
• 25 Travis W D, Borok Z, Roum J H et al.. Pulmonary Langerhans cell granulomatosis (histiocytosis X): a clinicopathologic study of 48 cases.  Am J Surg Pathol. 1993;  17 971-986
• 26 Tazi A, Bonay M, Bergeron A et al.. Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X.  Thorax. 1996;  51 611-614
• 27 Yousem S A, Colby T V, Chen Y Y et al.. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality.  Am J Surg Pathol. 2001;  25 630-636
• 28 Crausman R S, Jennings C A, Tuder R M et al.. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology.  Am J Respir Crit Care Med. 1996;  153 426-435
• 29 Fartoukh M, Humbert M, Capron F et al.. Severe pulmonary hypertension in histiocytosis X.  Am J Respir Crit Care Med. 2000;  161 216-223
• 30 Moore A D, Godwin J D, Muller N L et al.. Pulmonary histiocytosis X: comparison of radiographic and CT findings.  Radiology. 1989;  172 249-254
• 31 Brauner M W, Grenier P, Mouelhi M M et al.. Pulmonary histiocytosis X: evaluation with high-resolution CT.  Radiology. 1989;  172 255-258
• 32 Brauner M W, Grenier P, Tijani K et al.. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans.  Radiology. 1997;  204 497-502
• 33 Kulwiec E L, Lynch D A, Aguayo S M et al.. Imaging of pulmonary histiocytosis X.  Radiographics. 1992;  12 515-526
• 34 Colby T V, Lombard C. Histiocytosis X in the lung.  Hum Pathol. 1983;  14 847-856
• 35 Mogulkoc N, Veral A, Bishop P W et al.. Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation.  Chest. 1999;  115 1452-1455
• 36 Von Essen S, West W, Sitorius M et al.. Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X.  Chest. 1990;  98 765-767
• 37 Negrin-Dastis S, Butenda D, Dorzee J et al.. Complete disappearance of lung abnormalities on high-resolution computed tomography: a case of histiocytosis X.  Can Respir J. 2007;  14 235-237
• 38 Saven A, Burian C. Cladribine activity in adult Langerhans-cell histiocytosis.  Blood. 1999;  93 4125-4130
• 39 Pardanani A, Phyliky R L, Li C Y et al.. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis.  Mayo Clin Proc. 2003;  78 301-306
• 40 Goh N S, McDonald C E, MacGregor D P et al.. Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine.  Respirology. 2003;  8 91-94
• 41 Saven A, Foon K A, Piro L D. 2-Chlorodeoxyadenosine-induced complete remissions in Langerhans-cell histiocytosis.  Ann Intern Med. 1994;  121 430-432
• 42 Mendez J L, Nadrous H F, Vassallo R et al.. Pneumothorax in pulmonary Langerhans cell histiocytosis.  Chest. 2004;  125 1028-1032
• 43 Chaowalit N, Pellikka P A, Decker P A et al.. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis.  Mayo Clin Proc. 2004;  79 1269-1275
• 44 Gabbay E, Dark J H, Ashcroft T et al.. Recurrence of Langerhans' cell granulomatosis following lung transplantation.  Thorax. 1998;  53 326-327
• 45 Allen J N, Pacht E R, Gadek J E et al.. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure.  N Engl J Med. 1989;  321 569-574
• 46 Shorr A F, Scoville S L, Cersovsky S B et al.. Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq.  JAMA. 2004;  292 2997-3005
• 47 Watanabe K, Fujimura M, Kasahara K et al.. Acute eosinophilic pneumonia following cigarette smoking: a case report including cigarette-smoking challenge test.  Intern Med. 2002;  41 1016-1020
• 48 Al-Saieg N, Moammar O, Kartan R. Flavored cigar smoking induces acute eosinophilic pneumonia.  Chest. 2007;  131 1234-1237
• 49 Shintani H, Fujimura M, Yasui M et al.. Acute eosinophilic pneumonia caused by cigarette smoking.  Intern Med. 2000;  39 66-68
• 50 Baumgartner K B, Samet J M, Stidley C A et al.. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.  Am J Respir Crit Care Med. 1997;  155 242-248
• 51 Miyake Y, Sasaki S, Yokoyama T et al.. Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan.  Ann Occup Hyg. 2005;  49 259-265
• 52 Doyle J J, Eliasson A H, Argyros G J et al.. Prevalence of pulmonary disorders in patients with newly diagnosed rheumatoid arthritis.  Clin Rheumatol. 2000;  19 217-221